Tagged with Michael Good

Griffith University, the Institute for Glycomics and Rotary are thrilled to announce The Honourable Anna Bligh AC will become the inaugural National Ambassador for its Malaria Vaccine Project.

A Griffith study has found childhood COVID vaccination leads to high reductions in child disease and mortality, but is more beneficial to adults, particularly the unvaccinated.

Broad-spectrum malaria vaccine can be freeze-dried making it suitable for deployment into malaria-endemic countries.

Griffith University researchers have developed a new vaccine in pre-clinical studies to treat human babesiosis, a tick-transmitted disease closely related to malaria.

Using convalescent plasma, Griffith University researchers have identified how it may be possible to make a future vaccine that will provide protection against all major strains of COVID-19

Griffith University Institute for Glycomics researchers are closer to the development of a new vaccine aimed at preventing the deadly Streptococcus A (Strep A), which kills more than 500,000 people globally per year.

Partial immunity to SARS-CoV-2 combined with social distancing would significantly reduce mortality rates new mathematical modelling shows.